Regioselective Acetolysis of O-Benzylated Carbohydrates
temperature was left to gradually rise to room temp. over 2 h. The
mixture was then cooled to 0 °C, excess TEA (0.4 mL) was added,
and the vessel was left to spontaneously warm. About 1.5 h after
the addition of the base, the mixture was diluted with DCM, and
the organic phase was washed with aq. thiosulfate. The aqueous
phase was re-extracted with DCM, and the collected organic
phases were dried and concentrated in vacuo. The resulting crude
product was purified by silica gel flash chromatography, eluted by
hexane/ethyl acetate, 1:1 to yield 34 as an oil (74 mg, 93% yield).
2.5, 12.5 Hz, 1 H, 6a-H), 4.19 (dd, J = 5.5, 12.5 Hz, 1 H, 6b-H),
3.93 (t, J = 3.5 Hz, 1 H, 3-H), 3.85 (m, 1 H, 5-H), 3.55 (t, J = 3.5
and 9.5 Hz, 1 H, 4-H), 3.30 (s, 3 H, -OCH3), 2.02 (s, 3 H, -COCH3),
1.67 (s, 3 H, orthoester CH3) ppm. 13C NMR (125 MHz, CDCl3): δ
= 170.8, (-COCH3); 137.4 (ϫ2, aromatic C), 128.5–128.1 (aromatic
CH), 121.3 (orthoester C), 97.5 (1-C), 77.7, 74.9, 74.8, 72.4, 71.8,
68.4, 63.6, 50.7 and 20.8 ppm. MALDI-TOF MS: m/z = 481.35 [M
+ Na]+. C25H30O8 (458.19): calcd. C 65.49, H 6.60; found C 65.35,
H 6.75.
Allyl 6-O-Acetyl-2,3,4-tri-O-benzyl-α-
D-mannopyranoside (13): 4-O-Acetyl-3,6-di-O-benzyl-1,2-isopropylidene-α-
D
-glucopyranose
[α]2D8 = +30.2 (c = 1.20, CHCl3). 1H NMR (400 MHz, CDCl3): δ =
7.50–7.20 (aromatic H), 6.00–5.90 (m, 1 H, -OCH2CH=CH2), 5.27
(qd, J = 1.6, 17.2 Hz, 1 H, -OCH2CH=CHcisHtrans), 5.20 (qd, J =
1.6, 10.4 Hz, 1 H, -OCH2CH=CHcisHtrans), 4.94 (d, J = 1.6 Hz, 1
H, 1-H), 5.00–4.60 (2ϫ AB and s, 6 H, 3ϫ -CH2Ph), 4.38 (d, J =
(21) and 6-O-Acetyl-3,5-di-O-benzyl-1,2-isopropylidene-α-D-gluco-
furanose (22): 1H NMR (500 MHz, CDCl3): signals of 19 at δ =
7.40–7.20 (m, aromatic H), 5.65 (d, J = 5.0 Hz, 1 H, 1-H), 5.12
(dd, J = 1.5, 9.0 Hz, 1 H, 4-H), 4.84–4.54 (2 ϫ AB, 4 H, 2 ϫ
-CH2Ph), 4.23 (dd, J = 3.0, 5.0 Hz, 1 H, 2-H), 4.04 (m, 1 H, 5-H),
3.6 Hz, 2 H, 6-H2), 4.20–4.15 (m, 1 H, -OCHa HbCH=CH2), 4.05– 3.77 (t, J = 3.0 Hz, 1 H, 3-H), 3.62–3.55 (m, 2 H, 6-H2), 1.99 (s, 3
3.93 (overlapped signals, 3 H; 3-H, 5-H and -OCHaHbCH=CH2), H, -COCH3), 1.58 and 1.34 (2ϫ s, 6 H, 2 ϫ acetonide CH3) ppm.
3.90–3.80 (overlapped signals, 2 H, 2-H and 4-H), 2.10 (s, 3 H,
-COCH3) ppm. 13C NMR (100 MHz, CDCl3):
170.8 (m, 1 H, 2-H), 4.30 (dd, J = 3.0, 9.0 Hz, 1 H), 4.15 (dd, J = 5.0,
(-COCH3), 138.2, 138.1, 138.0 (aromatic C), 133.5 (-CH=CH2), 12.5 Hz, 1 H), 2.06 (s, 3 H, -COCH3), 1.49 and 1.32 (2ϫ s, 6 H,
Significant signals of 20 at δ = 5.90 (d, J = 3.5 Hz, 1 H, 1-H), 4.68
δ
=
128.5–127.5 (aromatic CH), 97.0 (1-C), 80.1, 75.2, 74.5 (ϫ2), 72.6,
72.1, 70.1, 67.9, 63.4; 20.8 (-COCH3) ppm. MALDI-TOF MS: m/z
= 555.35 [M + Na]+. C32H36O7 (522.25): calcd. C 72.16, H 6.81;
found C 72.30, H 6.75.
2ϫ acetonide CH3) ppm. 13C NMR (125 MHz, CDCl3) signals of
21 at δ = 170.1 (-COCH3), 138.0 and 137.7 (aromatic C), 128.4–
127.5 (aromatic CH), 109.4 (acetonide C), 96.9 (1-C), 75.7, 74.3,
73.4, 69.8, 68.4 (ϫ2); 26.3 and 25.4 (acetonide methyl groups), 21.0
(-COCH3) ppm. Significant signals of 22 at δ = 170.8 (-COCH3),
138.0 and 137.4 (aromatic C), 111.8 (acetonide C), 105.1 (1-C),
81.7, 81.6, 78.7, 74.2, 72.4, 71.9, 63.7; 26.8 and 26.3 (acetonide
methyl groups), 20.9 (-COCH3) ppm. MALDI-TOF MS: m/z =
465.50 [M + Na]+. C25H30O7 (442.51): calcd. C 67.86, H 6.83;
found C 67.70, H 6.85.
Allyl 6-O-Acetyl-3,4-di-O-benzyl-2-O-fluorenylmethoxycarbonyl-α-
D
-mannopyranoside (15): [α]2D8 = +13.3 (c = 1.47, CHCl3). 1H NMR
(400 MHz, CDCl3):
δ = 7.85–7.20 (aromatic H), 6.00–5.90
(m, 1 H, -OCH2CH=CH2), 5.32 (qd, J = 1.6, 17.2 Hz, 1 H,
-OCH2CH=CHcisHtrans), 5.30–5.24 (overlapped signals, 2 H, 2-H
and -OCH2CH=CHcisHtrans), 5.02 (d, J = 1.6 Hz, 1 H, 1-H), 5.00–
4.60 (2ϫ AB, 4 H, 2ϫ -CH2Ph), 4.49 (dd, J = 7.2, 10.0 Hz, 1 H,
4,6-Di-O-acetyl-3-O-benzyl-1,2-O-isopropylidene-α-D-glucopyranose
-OCHaHbCH-), 4.41 (d, J = 3.2 Hz, 2 H, 6-H2), 4.36 (dd, J = 7.6, (23): [α]2D4 = +17.4 (c = 1.15, CHCl3). 1H NMR (400 MHz, CDCl3):
10.0 Hz, 1 H, -OCHaHbCH-), 4.29 (bt, J = 7.2 Hz, 1 H, -OCH2CH- δ = –7.35–7.25 (m, aromatic H), 5.60 (d, J = 4.8 Hz, 1 H, 1-H), 4.99
), 4.25–4.20 (m, 1 H, -OCHaHbCH=CH2), 4.10 (dd, J = 3.2, 8.8 Hz,
1 H, 3-H), 4.04 (m, 1 H, -OCHaHbCH=CH2), 3.95–3.80 (over-
lapped signals, 2 H, 4-H and 5-H), 2.11 (s, 3 H, -COCH3) ppm.
δ = 170.8 (-COCH3), 154.6 and 2.05 (2ϫ s, 6 H, -COCH3), 1.56 and 1.30 (2ϫ s, 6 H, 2ϫ
(-OCO2-); 143.4, 143.1, 137.8 and 137.7 (aromatic C), 133.1, 128.5–
(dd, J = 2.0, 9.6 Hz, 1 H, 4-H), 4.80 and 4.68 (AB, J = 12.0 Hz, 2
H, -CH2Ph), 4.24 (dd, J = 3.2,4.8 Hz, 1 H, 2-H), 4.25–4.15 (m, 2
H, 6-H2), 4.06 (m, 1 H, 5-H), 3.77 (t, J = 3.0 Hz, 1 H, 3-H), 2.08
13C NMR (100 MHz, CDCl3):
acetonide CH3) ppm. 13C NMR (125 MHz, CDCl3): δ = 170.9,
170.1 (-COCH3), 137.5 (aromatic C), 128.4 and 127.9 (aromatic
127.6, 125.2, 125.0, 120.0 and 118.1 (aromatic CH), 96.5 (C-1),
78.1, 75.3, 73.8, 72.3, 71.7, 70.1, 69.7, 68.2, 63.2, 46.5; 20.8 CH), 109.5 (acetonide C), 96.8 (1-C), 75.8, 74.3, 71.7, 68.2, 67.1,
(-COCH3) ppm. MALDI-TOF MS: m/z = 687.10 [M + Na]+.
C40H40O9 (664.27): calcd. C 72.27, H 6.07; found C 72.40, H 6.05.
63.6; 26.4 and 25.4 (acetonide methyl groups), 21.0 and 20.9
(-COCH3) ppm. MALDI-TOF MS: m/z = 417.35 [M + Na]+.
C20H26O8 (394.36): calcd. C 60.90, H 6.64; found C 60.75, H 6.75.
Allyl 6-O-Acetyl-2,3,4-tri-O-benzyl-β-D
-glucopyranoside (17): [α]2D5
= +14.5 (c = 1.40, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.35–
7.20 (m, aromatic H), 6.00–5.90 (m, 1 H, -OCH2CH=CH2), 5.32
(qd, J = 1.6, 17.2 Hz, 1 H, -OCH2CH=CHcisHtrans), 5.23 (qd, J =
Allyl 6-O-Acetyl-3,4-di-O-benzyl-2-deoxy-2-phthalimido-β-D-gluco-
pyranoside (28): [α]2D8 = +46.3 (c = 0.67, CHCl3). 1H NMR
(500 MHz, CDCl3): δ = 7.70–6.80 (m, aromatic H), 5.60–5.70 (m,
1.6, 10.0 Hz, 1 H, -OCH2CH=CHcisHtrans), 5.00–4.55 (3ϫ AB, 12 1 H, -OCH2CH=CH2), 5.18 (d, J = 8.0 Hz, 1 H, 1-H), 5.11 (qd, J
H, 6ϫ -CH2Ph), 4.47 (d, J = 8.0 Hz, 1 H, 1-H), 4.45–4.35 (m, 1 = 1.5, 18.0 Hz, 1 H, -OCH2CH=CHcisHtrans), 5.23 (qd, J = 1.5,
H, -OCHa HbCH=CH2), 4.36 (dd, J = 2.0, 12.0 Hz, 2 H, 6a-H), 10.5 Hz, 1 H, -OCH2CH=CHcisHtrans), 4.90–4.40 (2ϫ AB, 4 H,
4.24 (dd, J = 4.8, 12.5 Hz, 2 H, 6b-H), 4.20–4.15 (m, 1 H, -OCHa-
HbCH=CH2), 3.69 (t, J = 9.6 Hz, 1 H, 3-H), 3.60–3.45 (overlapped
signals, 2 H, 2-H and 4-H), 2.02 (s, 3 H, COCH3) ppm. 13C NMR
(125 MHz, CDCl3): δ = 170.7 (-COCH3), 138.4, 138.3, 137.8 (aro-
matic C), 133.8 (CH=CH2), 128.5–127.4 (aromatic CH), 117.5
(CH=CH2), 101.9 (1-C), 84.6, 82.2, 77.4, 75.7, 75.0, 74.8, 72.8,
2ϫ -CH2Ph), 4.44 (t, J = 8.0, 10.5 Hz, 1 H, 3-H), 4.39 (dd, J =
7.5, 12.0 Hz, 1 H, 6a-H), 4.28 (dd, J = 3.5, 12.0 Hz, 1 H, 6b-H),
4.26–4.18 (overlapped signals, 2 H, 2-H and -OCHaHbCH=CH2),
4.00–3.97 (m, 1 H, -OCHaHbCH=CH2), 3.74–3.66 (overlapped sig-
nals, 2 H, 4-H and 5-H), 2.09 (s, 3 H, COCH3) ppm. 13C NMR
(100 MHz, CDCl3): δ = 170.8 (-COCH3), 137.8, 137.6, 131.6 (aro-
70.4, 63.1; 20.8 (-COCH3) ppm. MALDI-TOF MS: m/z = 555.20 matic C), 133.6 (CH=CH2), 133.7, 128.6–127.3 (aromatic CH),
[M + Na]+. C32H36O7 (532.25): calcd. C 72.16, H 6.81; found C
72.35, H 6.70.
117.4 (CH=CH2), 97.3 (1-C), 79.5, 79.4, 75.0, 74.9, 73.0, 69.9, 62.9,
55.8; 20.9 (-COCH3) ppm. MALDI-TOF MS: m/z = 594.40 [M +
Na]+. C33H33NO8 (571.22): calcd. C 69.34, H 5.82; found C 60.20,
H 5.90.
6-O-Acetyl-3,4-di-O-benzyl-1,2-O-(1-methoxy)ethylidene-α-
D-gluco-
pyranose (19): 1H NMR (500 MHz, CDCl3): δ = 7.40–7.20 (m, aro-
matic H), 5.73 (d, J = 5.0 Hz, 1 H, 1-H), 4.75–4.38 (3ϫ AB, 6 H, Allyl 2,3,4,6-Tetra-O-benzyl-β-
D-glucopyranosyl-(1Ǟ4)-3-O-acetyl-
3ϫ -CH2Ph), 4.58 (dd, J = 3.0, 5.0 Hz, 1 H, 2-H), 4.26 (dd, J = 2,6-di-O-benzyl-β-
D
-glucopyranoside (30): [α]2D4 = +28.8 (c = 1.00,
Eur. J. Org. Chem. 2013, 3137–3147
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3145